Denise Nardelli‐Haefliger

3.8k citations

82 papers · 3.0k indexed · h-index 32

Co-authors: John T. Schiller P. De Grandi Marty Shankland Alexandra Potts Patrice Jichlinski Martine Bobst Sonia Domingos‐Pereira Walter Wahli
Topics: Immunotherapy and Immune Responses (30 papers)Cervical Cancer and HPV Research (23 papers)Bladder and Urothelial Cancer Treatments (16 papers)
Cited by: Immunology Microbiology Epidemiology
Journals: Nucleic Acids Research Journal of Biological Chemistry Journal of Clinical Investigation
Partner nations: Switzerland United States France

In The Last Decade

Denise Nardelli‐Haefliger

79 papers receiving 2.9k citations

Peers

Countries citing papers authored by Denise Nardelli‐Haefliger

Since Specialization

Citations

This map shows the geographic impact of Denise Nardelli‐Haefliger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denise Nardelli‐Haefliger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denise Nardelli‐Haefliger more than expected).

Fields of papers citing papers by Denise Nardelli‐Haefliger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denise Nardelli‐Haefliger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denise Nardelli‐Haefliger. The network helps show where Denise Nardelli‐Haefliger may publish in the future.

Co-authorship network of co-authors of Denise Nardelli‐Haefliger

This figure shows the co-authorship network connecting the top 25 collaborators of Denise Nardelli‐Haefliger. A scholar is included among the top collaborators of Denise Nardelli‐Haefliger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denise Nardelli‐Haefliger. Denise Nardelli‐Haefliger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Intravesical Ty21a treatment of non-muscle invasive bladder cancer induces immune responses that correlate with safety and may be associated to therapy potential 2023 ·Journal for ImmunoTherapy of Cancer ·Laurent Derré,Ilaria Lucca,Valérie Cesson,Perrine Bohner,(unknown),(unknown),Florence Dartiguenave,(unknown),(unknown),Sulayman Benmerzoug,Mathieu F. Chevalier,Sonia Domingos‐Pereira,(unknown),(unknown),Anna K. Schneider,Patrice Jichlinski,Beat Roth,Denise Nardelli‐Haefliger	3
2	Novel intravesical bacterial immunotherapy induces rejection of BCG-unresponsive established bladder tumors 2022 ·Journal for ImmunoTherapy of Cancer ·(unknown),Santiago Uranga,(unknown),Ana Belén Gómez,Denise Nardelli‐Haefliger,Carlos del Fresno,(unknown),Eugenia Puentes,Esteban Rodríguez,Mar Valés‐Gómez,Julián Pardo,David Sancho,Carlos Martı́n,Nacho Aguiló	13
3	Vδ2 T cells are associated with favorable clinical outcomes in patients with bladder cancer and their tumor reactivity can be boosted by BCG and zoledronate treatments 2022 ·Journal for ImmunoTherapy of Cancer ·(unknown),Mathieu F. Chevalier,Sulayman Benmerzoug,Valérie Cesson,Anna K. Schneider,(unknown),Florence Dartiguenave,Ilaria Lucca,Patrice Jichlinski,Beat Roth,Denise Nardelli‐Haefliger,Laurent Derré	20
4	Tumor-Microenvironment Characterization of the MB49 Non-Muscle-Invasive Bladder-Cancer Orthotopic Model towards New Therapeutic Strategies 2022 ·International Journal of Molecular Sciences ·Sonia Domingos‐Pereira,(unknown),(unknown),Jacques‐Antoine Haefliger,(unknown),Carola H. Ries,Patrice Jichlinski,Beat Roth,Laurent Derré,Denise Nardelli‐Haefliger	7
5	Siglec-6 as a New Potential Immune Checkpoint for Bladder Cancer Patients 2021 ·European Urology Focus ·Sulayman Benmerzoug,Mathieu F. Chevalier,(unknown),(unknown),Valérie Cesson,Anna K. Schneider,Florence Dartiguenave,(unknown),Ilaria Lucca,Patrice Jichlinski,Beat Roth,Denise Nardelli‐Haefliger,Laurent Derré	12
6	Siglec-7 May Limit Natural Killer Cell–mediated Antitumor responses in Bladder Cancer Patients 2021 ·European Urology Open Science ·Sulayman Benmerzoug,Mathieu F. Chevalier,(unknown),(unknown),Valérie Cesson,Anna K. Schneider,Florence Dartiguenave,(unknown),Ilaria Lucca,Patrice Jichlinski,Beat Roth,Denise Nardelli‐Haefliger,Laurent Derré	9
7	Differentially regulated promoters for antigen expression in Salmonella vaccine strains 2020 ·Vaccine ·Miloš Stojanov,(unknown),(unknown),Denise Nardelli‐Haefliger,Roy Curtiss,David Baud	1
8	Intravesical Ty21a Vaccine Promotes Dendritic Cells and T Cell–Mediated Tumor Regression in the MB49 Bladder Cancer Model 2019 ·Cancer Immunology Research ·Sonia Domingos‐Pereira,(unknown),Stefano La Rosa,(unknown),Mathieu F. Chevalier,(unknown),(unknown),Laurent Derré,Jacques‐Antoine Haefliger,Patrice Jichlinski,Denise Nardelli‐Haefliger	21
9	Nanoparticle Conjugation of Human Papillomavirus 16 E7-long Peptides Enhances Therapeutic Vaccine Efficacy against Solid Tumors in Mice 2018 ·Cancer Immunology Research ·(unknown),Mélanie Tichet,Sonia Domingos‐Pereira,Sylvie Hauert,Denise Nardelli‐Haefliger,Melody A. Swartz,Douglas Hanahan,Stephan Wullschleger	30
10	Intramuscular Immunization Induces Antigen-specific Antibodies in Urine 2018 ·European Urology Focus ·Laurent Derré,Ilaria Lucca,Valérie Cesson,Massimo Valério,Yannick Cerantola,Rodolfo Burruni,(unknown),(unknown),Martine Bobst,(unknown),Florence Dartiguenave,Patrice Jichlinski,Denise Nardelli‐Haefliger	0
11	Targeting Cx40 (Connexin40) Expression or Function Reduces Angiogenesis in the Developing Mouse Retina 2017 ·Arteriosclerosis Thrombosis and Vascular Biology ·Jacques‐Antoine Haefliger,Florent Allagnat,(unknown),(unknown),Paolo Meda,Denise Nardelli‐Haefliger,Elisabeth Génot,Florian Alonso	26
12	Intravesical Bacillus Calmette Guerin Combined with a Cancer Vaccine Increases Local T-Cell Responses in Non-muscle–Invasive Bladder Cancer Patients 2016 ·Clinical Cancer Research ·Laurent Derré,Valérie Cesson,Ilaria Lucca,Yannick Cerantola,Massimo Valério,(unknown),(unknown),Rodolfo Burruni,(unknown),Florence Dartiguenave,(unknown),Virginie Martin,(unknown),Daniel E. Speiser,Pedro Romero,Patrice Jichlinski,Denise Nardelli‐Haefliger	34
13	Immunoregulation of Dendritic Cell Subsets by Inhibitory Receptors in Urothelial Cancer 2016 ·European Urology ·Mathieu F. Chevalier,Perrine Bohner,(unknown),Benoît Lhermitte,(unknown),(unknown),Samuel Rotman,Valérie Cesson,Virginie Martin,(unknown),Florence Dartiguenave,(unknown),Laurence de Leval,Daniel E. Speiser,Denise Nardelli‐Haefliger,Patrice Jichlinski,Laurent Derré	26
14	Intravaginal TLR agonists increase local vaccine-specific CD8 T cells and human papillomavirus-associated genital-tumor regression in mice 2012 ·Mucosal Immunology ·Sonia Domingos‐Pereira,(unknown),Laurent Derré,Martine Bobst,Pablo Romero,John T. Schiller,Patrice Jichlinski,Denise Nardelli‐Haefliger	59
15	Parenteral is more efficient than mucosal immunization to induce regression of human papillomavirus‐associated genital tumors 2011 ·International Journal of Cancer ·(unknown),Sonia Domingos‐Pereira,(unknown),Martine Bobst,Pedro Romero,John T. Schiller,Patrice Jichlinski,Denise Nardelli‐Haefliger	24
16	A novel mucosal orthotopic murine model of human papillomavirus‐associated genital cancers 2010 ·International Journal of Cancer ·(unknown),Ana Rita Gonçalves,Sonia Domingos‐Pereira,(unknown),Jean‐Christophe Stehle,John T. Schiller,Patrice Jichlinski,Denise Nardelli‐Haefliger	30
17	Chapter 17: Second generation HPV vaccines to prevent cervical cancer 2006 ·Vaccine ·John T. Schiller,Denise Nardelli‐Haefliger	42
18	Immune responses induced by lower airway mucosal immunisation with a human papillomavirus type 16 virus-like particle vaccine 2005 ·Vaccine ·Denise Nardelli‐Haefliger,(unknown),Daniel Wirthner,François Spertini,John T. Schiller,Douglas R. Lowy,(unknown),P. De Grandi	78
19	Mucosal Vaccination with a Recombinant Salmonella typhimurium Expressing Human Papillomavirus Type 16 (HPV16) L1 Virus-like Particles (VLPs) or HPV16 VLPs Purified from Insect Cells Inhibits the Growth of HPV16-Expressing Tumor Cells in Mice 2001 ·Virology ·(unknown),Jalil Benyacoub,W. Martin Kast,John T. Schiller,P. De Grandi,Denise Nardelli‐Haefliger	38
20	The distribution of the dinucleotide CpG and cytosine methylation in the vitellogenin gene family 1987 ·Journal of Molecular Evolution ·D.N. Cooper,Susan Gerber-Huber,Denise Nardelli‐Haefliger,(unknown),Walter Wahli	16

About Denise Nardelli‐Haefliger

Denise Nardelli‐Haefliger is a scholar working on Immunology, Biotechnology and Epidemiology, having authored 82 papers that have together received 3.0k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (30 papers), Cervical Cancer and HPV Research (23 papers) and Bladder and Urothelial Cancer Treatments (16 papers). The work is most often cited by research in Immunology (1.3k citations), Microbiology (228 citations) and Epidemiology (1.0k citations). Denise Nardelli‐Haefliger has collaborated with scholars based in Switzerland, United States and France. Frequent co-authors include John T. Schiller, P. De Grandi, Marty Shankland, Alexandra Potts, Patrice Jichlinski, Martine Bobst, Sonia Domingos‐Pereira, Walter Wahli, Laurent Derré and Richard B.S. Roden. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Journal of Clinical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact